Nasdaq
CVKD
Cadrenal Therapeutics, Inc.
- Health Care
- Listed 2023
- 1 day
- −4.6%
- 1 month
- −40.8%
- 1 year
- −82.9%
$1.87 · Mkt cap $6.67M
At the 6 Aug 2026 close
Nasdaq
Cadrenal Therapeutics, Inc.
$1.87 · Mkt cap $6.67M
At the 6 Aug 2026 close
Cadrenal Therapeutics, Inc. trades under the ticker CVKD on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). It has been listed since 2023. Its market capitalisation is $6.67M. The last closing price was $1.87, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is −82.9%, and −40.8% over the past month. Returns are price returns and exclude dividends.
This page exists because CVKD is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.